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Abstract  
L-selectin (CD62L) is a type I transmembrane glycoprotein and cell adhesion 
molecule that is expressed in most circulating leukocytes. L-selectin is broadly 
characterized as an anchor/bearing receptor. There is currently emerging 
evidence suggesting that L-selectin has a role in regulating monocyte 
protrusion during transendothelial migration (TEM). The lectin domain is N-
terminal calcium-dependent (type C) interacts with numerous glycans, 
important to name sialyl Lewis X (sLex) for anchoring/coiling and proteoglycans 
for endothelial transmigration. The short cytoplasmic tail of 17 amino acids is 
responsible for adhesion. The ability of leukocytes to migrate from the 
periphery to tissues is a critical step in the immune response, with several 
adhesion molecules being involved in this process. This molecule is expressed 
on the surface of lymphocytes, neutrophils, monocytes, eosinophils, 
hematopoietic precursor cells, and immature thymocytes. L-selectin is a highly 
glycosylated protein of 95-105 kD in neutrophils and 74 kD in lymphocytes. It is 
involved in lymphocyte migration to peripheral lymph nodes through interaction 
with GlyCAM-110 and in the adhesion of lymphocytes, neutrophils and 
monocytes to the endothelium activated by cytokines at sites of inflammation. 
Several L-selectin ligands have been identified on endothelial cells, GlyCAM-1, 
CD34 and MAdCAM-1, all containing glycosylated mucin domains. The soluble 
form of L-selectin (sL-selectin) is present in plasma due to metalloproteinase-
mediated cleavage of L-selectin expressed on the cell surface. The soluble 
form retains bioactivity and at high concentrations can inhibit the binding of 
lymphocytes to the endothelium, suggesting their possible role in vivo. While 
sL-selectin can be detected in the circulation of healthy individuals from 0.7 to 
1.5ug/ml, increased levels have been reported in patients with sepsis, 
inflammatory, autoimmune diseases and in leukemias.  An indirect approach to 
measure sL-selectin is by means of the shedding of CD62L from the membrane 
of leukocytes. In this work we set up a method to measure it in vitro in order to 
apply it in the clinical management in patients with suspicion of 
immunodeficiency 
Keywords:  Diapedesis, Inmunodefficiency, L-selectin, Lymphocytes, Shedding. 
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1. INTRODUCTION 
 
1.1 The steps in the process of inflammation and extravascular migration. 
There are various stimuli that can cause tissue injury, either exogenous or 
endogenous, that can cause the inflammatory response (IR) in the vascularized 
connective tissue. This vascular reaction results in the infiltration and 
accumulation of fluid and leukocytes in the extravascular tissues.(1,2) 
The five cardinal signs of inflammation are: flushing, tumour, heat, pain, and 
functional impotence (Virchow's sign). (3) 
The IR is closely related to the repair process. IR is useful for destroying, 
attenuating, or keeping the damaging agent localized, and simultaneously 
initiates a series of events that can determine the healing or reconstruction of 
injured tissue. Hence, inflammation is considered to be primarily a protective 
response, and in the absence of this process, infections would spread 
uncontrollably, wounds would never heal, and injured organs would present 
suppurative lesions permanently. However, in certain situations, such as 
allergic reactions and chronic diseases, the inflammatory process constitutes 
the basic pathogenic mechanism. (1-4) 
The inflammation presents two well differentiated phases: acute and chronic. 
Acute inflammation has a relatively brief evolution; Its fundamental 
characteristics are the exudation of liquid and plasma proteins (edema), and 
the migration of leukocytes (mainly neutrophils). Chronic inflammation lasts 
longer and is characterized by proliferation of blood vessels, fibrosis, and tissue 
necrosis. (5-7) 
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1.1 What are the cellular and molecular elements involved in Acute 
Inflammatory Response that cause all the events of inflammation? 
There are several elements involved in Acute Inflammatory Response (AIR). 
Among them, we will consider: plasma, circulating cells (neutrophils, 
monocytes, eosinophils, basophils and lymphocytes), blood vessels and 
connective tissue cells (mast cells, fibroblasts and macrophages) and 
extracellular matrix components (collagen, elastin, adhesion glycoproteins such 
as fibronectin, laminin, non-fibrillar collagen, tenascin, and proteoglycans) of 
the connective tissue. In addition, the cellular and vascular responses of AIR 
are mediated by chemical factors from plasma or cells that are activated by the 
inflammatory stimulus itself. These mediators act independently, sequentially or 
in combination, and in later phases they amplify the IR and influence its 
evolution. Necrotic cells and tissues can also trigger the formation of chemical 
mediators. (5-7) 
1.1.1. Vascular events 
Secondary to injury, whatever its nature, there is an inconsistent and 
transient period of arteriolar vasoconstriction. Then, certain amounts of 
histamine appear at the damaged site, causing vasodilation and active 
hyperemia (increased blood flow in the area of the lesion), which causes 
redness and an increase in temperature.(3) 
Histamine is the mediator of the acute phase and is stored in granules of 
mast cells, basophils and platelets. It is secreted in response to physical 
injuries, such as trauma, cold or heat; or in the presence of inflammatory 
agents such as complement molecules (C3a, C5a), lysosomal proteins, or 
interleukins (IL) IL1, IL8. (4-6) 
Another mediator that may appear at the injured site is nitric oxide (NO), 
released in this case by endothelial cells in response to the injurious stimulus. 
Its main action is vasodilation through relaxation of the smooth muscle of the 
vascular wall. In addition to endothelial cells, it is also produced by specific 
neurons and macrophages. It is synthesized from L-arginine, molecular 
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oxygen, nicotinamide-adenine dinucleotide reduced phosphate (NADPH) and 
other cofactors, by action of the enzyme nitric oxide synthase (NOS). 
Endothelial NOS is rapidly activated by increased cytosolic calcium. (6-7) 
Later, a slowdown in local blood flow occurs, secondary to a progressive 
increase in vascular permeability with extravasation of fluid and an increase in 
blood viscosity in vessels of smaller size, determining the establishment of the 
state of vascular stasis. As stasis evolves, peripheral orientation 
(marginalization) of leukocytes occurs, attaching to the endothelium, crossing 
the vascular wall, and targeting the interstitium. 
The vascular events that occur in inflammation can be summarized in the 
following order: 
1. Arteriolar and capillary vasodilation, which causes capillaries and 
venules to open, induced by the action of different mediators on vascular 
smooth muscle, mainly histamine and nitric oxide. 
2. Increased blood flow through the arterioles, which is the cause of the 
appearance of erythema (flushing) at the site of inflammation. 
3. Increased permeability of the microvasculature, leakage of an 
inflammatory exudate into extravascular tissues, and the appearance of 
inflammatory edema. 
4. Abnormal and excessive accumulation of blood, the leakage of fluid 
causes an increase in the viscosity of the blood, which increases the 
concentration of red blood cells (venous congestion). 
5. Decreased blood speed in small vessels (blood stasis). 
6. Peripheral accumulation of leukocytes, marginalization and leukocyte 
paving. 
7. At the same time, endothelial cells are activated by the mediators of 
inflammation, expressing molecules in their membranes that favor the 
adhesion of leukocytes, mainly polymorphonuclear neutrophils (PMN). 
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8. Leukocyte passage (PMN first, followed by macrophages) from the 
vessels to the interstitium: cell migration, with formation of the 
inflammatory infiltrate 
 
The alteration of the permeability constitutes the main characteristic and of 
greater specificity of the AIR, causing the profuse exudate towards the 
interstitium. Loss of plasma proteins reduces intravascular osmotic pressure 
but increase in interstitium. After vasodilation, intravascular hydrostatic 
pressure increased and leads to a significant leakage and accumulation of fluid 
in the interstitial tissue, eventually forming edema. 
The increase in vascular permeability is generated by several mechanisms, 
which can occur simultaneously. 
* First, the formation of openings between endothelial cells of venules. This 
mechanism is activated by histamine, bradykinin, leukotrienes, substance P, 
and other types of chemical mediators. This form of filtration only affects 
venules. The process appears to be mediated by intracellular agonist 
mechanisms, where endothelial cell contractile proteins phosphorylation is 
involved, which is known as an immediate response. Bradykinin (another 
mediator) is released by activation of the kinin system. This system generates 
vasoactive peptides from plasma proteins called kininogens and through 
specific proteases called kallikreins; one of these vasoactive peptides is 
bradykinin, a powerful inducer of increased vascular permeability, as well as 
pain. The kinin system is activated by Hageman's factor (XII of coagulation), 
which in turn is activated by injury to the vascular wall and expression of 
negative charges (collagen and basement membrane). (6) Leukotrienes (lipid 
mediator) are products of the metabolism of arachidonic acid (AA). AA is a 20-
carbon polyunsaturated fatty acid (5, 8, 11, 14-eicosatetraenoic acid), found 
inside cells esterified with membrane phospholipids. Upon mechanical, 
chemical (platelet activating factor, C5a) and physical stimuli, cellular 
phospholipases are activated, which liberate AA from its union with the 
membrane. AA metabolites (eicosanoids) are synthesized by two classes of 
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enzymes: cyclooxygenases (obtaining prostaglandin and thromboxanes) and 
lipoxygenases (obtaining leukotrienes and lipoxins). (7) Prostaglandin G2 
(PGG2) is the main metabolite of the cyclooxygenase pathway. In mast cells it 
is found together with prostaglandins E2 (PGE2) and F2α (PGF2α), which have 
a wider distribution. PGG2 leads to vasodilation and enhance the formation of 
edema. In the case of substance P it must be stated that it plays an important 
role in the initiation of IR. It constitutes a neuropeptide (abundant in nerve 
fibers of the lung and the gastrointestinal system). It is a powerful mediator of 
the increase in vascular permeability; It is also involved in the transmission of 
painful signals, regulation of blood pressure and stimulation of secretion by 
immune and endocrine cells. (8-10) 
* Cytoskeleton reorganization (endothelial retraction): Interleukin-1 (IL-1), tumor 
necrosis factor (TNF) and interferon gamma (IFN-y) are involved in this 
process, as well as hypoxia. It is known as a late response. IL-1 and TNF share 
many biological properties, and are produced by activated macrophages. Its 
secretion can be stimulated by physical injuries, endotoxins, immunocomplexes 
and toxins. (11-12) Regarding the increase of permeability, these cytokines 
induce the synthesis of endothelial adhesion molecules and other cytokines, 
chemokines, growth factors, eicosanoids and NO. They also induce the 
synthesis of enzymes associated with the remodelling of the matrix, are 
prothrombotic factors, and stimulate the synthesis and activity of collagenase 
enzymes. TNF also induces aggregation and priming of neutrophils, releasing 
proteolytic enzymes, contributing to tissue damage. (13) 
* Increased trancytosis: The transport of fluids and proteins through the 
endothelial cells themselves (and not between them) can be carried out 
through channels that are formed from interconnected vacuoles and uncoated 
vesicles (called vesiculovacuolar organelle). Vascular endothelial growth factor 
(VEGF) appears to stimulate the number and size of these channels. 
* Direct endothelial injury, with necrosis and detachment of endothelial cells: 
necrosis of endothelial cells causes their separation from the vessel wall, 
thereby creating an opening in it. It can occur in severe wounds, such as burns, 
or by the toxic action of microbes that directly affect the endothelium. PMNs 
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that adhere to endothelial cells can also damage them. In this case, fluid loss 
continues until a thrombus forms or damage is repaired. It is known as a 
prolonged immediate response. (14) 
* Leukocyte-mediated endothelial lesion: leukocytes attached to the 
endothelium release toxic forms of oxygen and proteolytic enzymes that end up 
damaging the endothelium, with a consequent increase in permeability. 
 
1.1.2. Cellular events: 
One of the characteristic and important function of inflammation is the 
contribution of leukocytes to the area of injury. Leukocytes phagocytize 
pathogens, destroy bacteria and microorganisms, and degrade necrotic tissue, 
but they can also prolong tissue damage by releasing enzymes, chemical 
mediators, and reactive oxygen species (oxygen free radicals, RLO). (6 -10) 
The sequence of events that occur from the leukocytes leaving the vascular 
lumen until they reach the interstitial tissue (extravasation) can be divided into: 
1. Intravascular: marginalization, rolling and adhesion. 
When blood flow is normal, erythrocytes and leukocytes in vessels remain 
confined to a central axial column. As the speed of blood flow decreases in 
the early stages of inflammation, due to increased vascular permeability; 
hemodynamic conditions are modified (shear forces on the wall decrease) 
and a greater number of leukocytes is located towards the periphery, along 
the endothelial surface. This leukocyte accumulation process. 
 
2 Transmigration through the endothelium (diapedesis). 
The leukocytes direct their pseudopodia toward the junctions between 
endothelial cells, enter tightly through them, and are located between the 
endothelial cell and the basement membrane. Finally they cross the basement 
membrane and exit into the extravascular space. This exit mechanism is used 
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by neutrophils, monocytes, lymphocytes, eosinophils, and basophils. It is 
known that leukocyte adhesion and transmigration are primarily determined by 
the binding of complementary adhesion molecules to the surface of leukocytes 
and endothelial cells, and that chemical mediators (chemotactic factors and 
certain cytokines) influence these processes by regulating expression. surface 
and binding intensity of these adhesion molecules 
 
3 Migration in the interstitial tissues towards a chemotactic stimulus. 
According to a chemical gradient. All granulocytes, monocytes and to a lesser 
extent lymphocytes, respond to chemotactic stimuli with different degrees of 
speed. 
Exogenous and endogenous substances can act as chemotactic factors: 
Exogenous: bacterial products. Endogenous: components of the complement 
system, especially C5a, products of the lipoxygenase pathway, mainly 
leukotriene B and cytokines 
The binding of chemotactic agents to specific receptors located on the 
leukocyte cell membrane leads to reactions that produce an increase in 
cytosolic calcium, a factor that triggers the assembly of the contractile elements 
responsible for cell movement. 
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2. Importance of adhesion molecules and main types. 
It is well-known that adhesion and transmigration are fundamentally 
determined by the binding of complementary adhesion molecules to the 
surface of leukocytes and endothelial cells, and that chemotactic factors 
and some cytokines influence these processes by regulating surface 
expression and intensity of fixation of these adhesion molecules. (9-12)  
Inflammation requires leukocytes to pass from the bloodstream into the 
tissues, basically the neutrophils and monocytes are the ones that move 
to the inflamed tissues in response to local stimuli. In the first phase of 
cell adhesion, selectins intervene reversibly, and leukocytes are rolled by 
the inflamed endothelium. In a second phase, the binding or arrest of 
leukocytes to the endothelium and the activation of neutrophils by the 
complement fragment C5a, PAF (platelet-activating factor), and 
interleukin 8 (IL-8), as well as by the FMLP peptide (n-formyl-methionyl-
leucyl-phenylalanine). The next step is a firm binding of the cell to the 
endothelium, intervening for this purpose adhesion molecules that belong 
to the immunoglobulin superfamily, such as ICAM-1 (intercellular 
adhesion molecules-1) and VCAM (vascular adhesion molecules-1). And 
lastly, a change in the shape of the cell occurs, allowing extravasation. 
Some authors also call this cascade as the metastatic cascade, because 
the same steps of the adhesion cascade are used for the dissemination 
of certain tumor cells, which are in the bloodstream and pass through the 
endothelium. (11-14) 
The adhesion receptors correspond to: 
Selectins: they have an extracellular N-terminal region related to sugar-
binding lectins, E-selectin (confined to the endothelium), P-selectin 
(present in the endothelium and platelets), and L-selectin (in leukocytes). 
They bind to the sialylated forms of the oligosaccharides, which in turn 
are covalently linked to mucin-type glycoproteins. 
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Immunoglobulins superfamily: ICAM-1 (intercellular adhesion molecule 
type 1) and VCAM-1 (vascular adhesion molecule type 1); both are 
endothelially adherent and interact with the leukocyte integrins. 
Integrins: glycoproteins of transmembrane adhesion. The main integrin-
like receptors are: for ICAM-1 the beta integrins (LFA-1 and MAC-1; for 
VCAM-1 the integrins α4β1 (VLA-4) and α4β7. (9-14) 
2.1. How are these molecules regulated to induce leukocyte adhesion in 
inflammation? 
* Redistribution of adhesion molecules to the cell surface: P-selectin is 
normally found in the membrane of intracytoplasmic granules (Weibel-
Palade bodies). Being stimulated by histamine, thrombin, and platelet 
activating factor (PAF), P-selectin is redistributed to the cell surface, 
where it can fix leukocytes, it is important in the initial phase of leukocyte 
bearing. (7 -14) PAF is a chemical mediator derived from phospholipids. 
From the chemical point of view it is an acetyl-glyceryl-ether-
phosphorylcholine. It is produced by mast cells, basophils, neutrophils, 
monocytes, macrophages, endotheliocytes, and platelets. It performs its 
effects through a receptor coupled to a G protein (activation of the 
second messenger). In addition to inducing leukocyte adhesion to the 
endothelium, it also causes degranulation, chemotaxis, oxidative burst, 
platelet aggregation, and in high concentrations causes vasoconstriction 
and bronchoconstriction. (13-14) 
* Induction of adhesion molecules on the endothelium: cytokines (IL-1 
and TNF) induce the synthesis and expression on surfaces of endothelial 
adhesion molecules. E-selectin, which does not normally exist in the 
endothelium, is induced by IL-1 and TNF, and acts as a mediator of the 
adhesion of neutrophils, monocytes, and certain lymphocytes by binding 
to their receptors.12 These cytokines also activate ICAM-1 and VCAM-1. 
(12-14) 
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* Increased binding intensity: This is the most important mechanism for 
the attachment of integrins. For LFA-1 to bind to ICAM-1, neutrophils 
must be activated, so that LFA-1 goes from a low-affinity state to a high-
affinity state for ICAM-1, because the integrin undergoes a 
transformational type transformation. The main agents that cause this 
leukocyte activation are chemokines, made by the endothelium or by 
other cells that come from the area of injury. During inflammation, the 
increased affinity of LFA-1, together with the increased expression of 
ICAM-1, determines the necessary conditions for a tight leukocyte-
endothelium binding to occur. The VCAM-1 interaction seems to be a 
necessary element for the subsequent transmigration through the 
endothelium. (10-14) 
 
3.1. L-selectin gene expression  
Located on the long arm of chromosome 1 (1q24.2), it is organized in 
tandem with the members of its family (in the order: L-, P- and E-selectin). 
Its gene consists of ten exons spanning a 21.0 kb region. This human gene 
is regulated by FOX01 (15,16), and chromosomal immunoprecipitation has 
been able to identify some others (Mzf1, Klf2, Sp1, Ets1 and Irf1) (17). The 
molecular weight of L-selectin differs between cell types, ranging from 70 
kDa in lymphocytes to 100 kDa in neutrophils, and depends on the cell-
type specific glycosylation. The altered glycosylation patterns in L-selectin 
may promote cell-specific functions, although this is not yet perfectly 
described. L-selectin is made up of structural compartments: a calcium-
dependent lectin domain (type C) (CTLD), an EGF-like domain, two 
repeated complement-like sequences, and an extracellular cleavage site. 
(18) 
Different L-selectin splices have been classified into murine models and 
human models. The mouse cell gene was made up of 9 exons. The two 
splice variants, classified as L-selectin-v1 and Lselectin-v2, have an 
additional exon, created between exons 7 and 8. The different splices 
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share the first sequence of 49 bp, while L- selectin-v2 spans an additional 
51 bp. that's immediately 3 'to this region. These splice variants are 
characterized by having longer cytoplasmic tails (WT = 17 aa; v1 = 30 aa; 
v2 = 32aa; see Figure 1). Overall, levels of L-selectin-v1 and -v2 mRNA 
make up 23% of total L-selectin mRNA, so its impact on trafficking and 
endogenous leukocyte signalling is not fully understood. The human splice 
variant does not have exon 7, it is in charge of encoding the 
transmembrane domain. Thus, transcripts that lack this exon are secreted 
and soluble. Patients with rheumatic diseases have a higher prevalence of 
splice variant transcription (16). 
 
 
Figure 1. Organization of the L-selectin domain. (L-. When going from N-
terminal to C-terminal, it is broken down into: C-type lectin domain (CTLD), 
epidermal growth factor (EGF), two sequence consensus repeat domains 
(SCR), section of cleavage, transmembrane domain and a 17 amino acid 
cytoplasmic tail. The amino acid sequence of the cytoplasmic tail of human 
L-selectin is shown, highlighting the amino acids that support binding to 
calmodulin (CaM), ERM proteins and alpha-actinin (A) All three sequences 
belong to the mouse L-selectin tail (note that the mouse L-selectin tail has a 
single serine at position 364, whereas the human L-selectin tail has a 
residue of additional serine at position 367. Conservation of the sequence in 
the proximal region of the membrane that supports binding to ERM and 
CaM (RRLKKG) is 100% conserved. The amino acid sequences of two L-
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selectin splice variants of mouse (v1 and v2) are provided in the sequences 
below. The underlined residues represent sequences that are unique to v1 
and v2 (B). Amino acid sequences surrounding the mouse and human L-
selectin cleavage site. The arrow indicates the cleavage position. TM, 
transmembrane domain; SCR, consensus sequence repeated region 
(C)(17) 
3.2 Organization of L-Selectin 
L-selectin is similar in extracellular domains to E- and P-selectin (Figure 1A). 
On the other hand, the cytoplasmic tails of members of the selectin family are 
not similar, probably transmitting unique intracellular signals. 
We begin with the possession of CTLD at the N-terminus (19), which belongs 
to a large superfamily of metazoan proteins with different functions (17-18). It 
has the function of anchoring and rolling the leukocytes by working together 
with the minimal tetrasaccharide determinant, sLex (14). A unique ability of 
selectins is to stabilize bond life with conformational changes in the CTLD 
determined by an external force such as hydrodynamic shear capacity. E-
selectin mutation product showed the existence of coordinated links between 
Ca2 + and amino acid residues within the upper face of the CTLD stabilizing 
interaction (15,16). Fucose 3 and 4-hydroxyl groups in sLex also form a 
coordinated Ca2 + bond, which collectively stabilize the selectin / ligand binding 
(17). L-selectin binding to sLex is characterized by a critical shear stress 
threshold condition (typically between 0.3 and 1.0 dynes per cm2). L-selectin 
binding depends on a 'catch' and 'slip' binding mechanism, where optimal shear 
stress conditions can expose more of the ligand binding domain and increase 
adhesiveness, and where an increase in pulling force eventually exceeds the 
threshold of the catch link (18). 
X-ray crystallographic evidence of selectins reveals that the CTLD folds into an 
EGF-like region of the domain, linked by a hydrogen bond between Y37 and 
N138 (20). This interaction between domains restricts L-selectin to a less 
adhesive conformation while in circulation. The functional significance of this 
interaction was characterized in neutrophils, where the decoupling of the Y37 / 
N138 hydrogen bond increases the useful life of the bond, which is manifested 
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in a greater priming of neutrophils within the circulation (20-23). Neutrophils 
carrying an N138G knock-in mutation within L-selectin showed increased 
bacterial destruction and worsened results in sterile lesion models. Both 
phenotypes were directly related to the increased preparation of neutrophils, 
confirming the causality of the knock-in mutation. This mode of 
"mechanochemistry" has been suggested to exist in other L-selectin expressing 
immune cells (24). 
SCR Domains are found variably and determined SCR (in humans L-selectin 
has 2, E-selectin has 6 and P-selectin has 9), which have homology to 
complement regulatory proteins. They are called "sushi domains" and are 
present in several different cell adhesion molecules (24). The function of the 
SCR serves to distance the CTLD from the plasma membrane, seeking, the 
extension beyond other cell adhesion molecules, to support the anchorage and 
rolling behavior. The possibility studied of why L-selectin has less than the 
members of its family is due to morphology because it is anchored to microvilli, 
which gives it an advantageous position for anchorage under flow. 
The Cleavage domain (Figure 1C) is essential since L-selectin undergoes 
ectodomain shedding at a specific membrane proximal location, eleven amino 
acids above the transmembrane domain, this fact occurs between K321 and 
S322. (25) Alanine scan mutations surrounding the cleavage site would 
suggest redundancy. Deletion of multiple amino acids suggests that the actual 
distance of the cleavage site from the plasma membrane is more important 
(26). ADAM17-inactivated mice reveal the accumulation of L-selectin on the 
surface of neutrophils and monocytes, suggesting that both induced 
ectodomain turnover and elimination are mediated by a similar enzyme. Due to 
the relaxed specificity of the L-selectin cleavage site, it is difficult to definitively 
state that both basal and activated K321 / S322 detachment. We are in the 
position that the binding of calmodulin to the cytoplasmic domain of L-selectin 
regulates the conformation of the cleavage site (27)). 
The cytoplasmic Tail in composed of intracellular proteins, including: 
alpha-actinin (28), calmodulin ezrin, moesin (29), protein kinase C (PKC) 
isoenzymes (30) and μ1alpha / AP-1 (31). Given the size of the L-selectin 
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tail, not all of these proteins can bind simultaneously, but they are likely to 
interact under strong spatio-temporal constraints, for example during 
anchoring, rolling, firm adhesion, and TEM. More of this will be discussed 
in the section below. 
Removing the 16 C-terminal amino acids from the tail of L-selectin can 
dramatically affect its lateral mobility along the plane of the plasma 
membrane, caused by the lack of anchorage to the underlying cortical 
actin-based cytoskeleton (32). Such large truncation can interrupt 
immobilization dynamics under flow conditions (33) and reduce the 
efficiency of L-selectin release. 
 
Alpha-Actinin is In charge of crosslinking classic actin filaments. There 
are isoforms (1 to 4), each encoded by a different gene and differentially 
expressed. Isoforms 1 and 4 are expressed in non-muscle cells and have 
molecular weights of approximately 100 kDa when highlighted in 
polyacrylamide. In contrast, isoforms 2 and 3 are shown in skeletal and 
cardiac muscle cells. Deletion of the 11 C-terminal amino acids from L-
selectin (called ‘LΔCyto ') nullifies the interaction with alpha actinin binding 
(35). Injection of cell lines expressing LΔCyto Lselectin into the circulation 
of rats revealed a significant reduction in rolling efficiency within the 
inflamed mesenteric parenchyma venules (36). They claim the 
requirement of the L-selectin cytoplasmic tail in the regulation of rolling 
interactions. However, little is known about how alpha-actinin interacts 
with L-selectin and whether the interaction is regulated by phosphorylation 
(serine / tyrosine) of the L-selectin tail or the production of secondary 
messengers (eg, Ca2 + ). Alpha-actinin isoforms 1 and 4 possess CaM-
type EF hands, which can bind Ca2 + and inhibit actin crosslinking activity. 
Interestingly, isoforms 1 and 4 expressed in smooth muscle cells (as in 
chicken gizzard) exist as splice variants of the EF domain that are 
insensitive to Ca2 + (37). Pavalko et al. They probably use Ca2 + 
sensitive and insensitive forms of alpha-actinin. It is currently unclear 
whether Ca2 + binding to alpha-actinin could play an active role in 
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regulating L-selectin binding. Despite its conserved identity with CaM, the 
EF-hand of alpha-actinin is not believed to interact with L-selectin since 
the amino acids that support the binding of CaM and alpha-actinin are 
found at opposite ends of the tail of L -selectin (37). Non-muscular alpha-
actinin is known to bind to other tails of cell adhesion molecules and has 
been extensively reviewed elsewhere (38). 
 
Calmodulin (CaM) is the protein responsible for adhering to 18 kDa 
calcium, identified by immunoprecipitation, and was subsequently 
confirmed by in vitro solid phase binding assays. It is at a resting state 
when Cam joins L-Selectin. Upon cell stimulation, CaM dissociates to 
promote an allosteric change at the cleavage site to drive ectodomain 
clearance by ADAM17. Serine 364, but not S367, in human L-selectin has 
been shown to be responsible for dissociation of CaM from L-selectin. In 
fact, the mutation of S364 to alanine significantly reduces forbol myristate 
acetate-induced release (PMA). (39) 
 
(ERM) Proteins are classified as 3-membered cytoskeletal proteins 
weighing 75-80 kDa. They all contain very similar domains: a globular N-
terminal domain, which belongs to the ezrin-radixinmoesin (FERM) of 
band 4.1, a central alpha-helical domain and an acid actin binding domain 
(see Figure 2A). The main role of ERM is to serve as linkers of the 
membrane cytoskeleton. Moreover, it is increasingly evident that they play 
essential roles in mediating signal transduction. Overexpression of L-
selectin in fibroblasts can lead to the formation of filopodia-like extensions. 
ERM proteins have the ability to actively participate in the formation of 
microvilli (40,41). The ERM conformation when inactive is folding, 
phosphatidylinositol 4,5bisphosphate allows it to open (Figure 2B) (42-44). 
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Figure 2 (A) Organization of the ERM domain: X-ray crystallographic studies 
determine the N-terminal domain. FERM contains a globular clover leaf shape 
(determined by 3 different subdomains) (the blue box indicates the residue 
numbers that make up each subdomain. (B) The FERM domain contains 
several interaction sites: a cryptic ITAM (the sequence is shown, which can 
recruit Syk, a PIP2 binding site and a region responsible for L-selectin binding. 
Tyrosine kinase Lck is responsible for Y145 phosphorylation of the FERM 
domain in T cells. Phosphorylation of Src from Y353 in the ezrin core coil 
domain can lead to the recruitment of PI3K class I, via the p85 regulatory 
subunit. are specifically classified as membrane / cytoskeleton crosslinkers. 
Recent evidence specifically that ezrin may be involved in the regulation of 
intracellular signaling  while moesin regulates L-selectin clustering before 
ADAM17 removes its ectodomain. A pathway where ERMs are inactivated in T 
cells has been detected, where binding of CXCR4 to CXCL12 leads to rapid 
dephosphorylation and collapse of ERM microvillar 
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AP-1 Adaptin (μ1A) is composed of clathrin-coated vesicles, was identified in 
classical deployable experiments and then verified by protein-protein 
interaction (47).  
μ1A drives the transport of de novo synthesized L-selectin from the trans Golgi 
network to the plasma membrane. The mode of interaction induced by PMA 
could suggest that MRF is internalized by virtue of the µ1A binding, once L-
selectin removal is complete. Full-length L-selectin can be internalized by μ1A 
and taken to an endosomal recycling compartment for re-expression back to 
the plasma membrane at a later stage during lymph node trafficking (45). 
 
3.3  Regulation of L-Selectin Protein Expression 
Modification of the actin cytoskeleton and elevated CD62L of the bone marrow 
of a neonate clarifies that L-selectin is one of the first surface markers that is 
expressed in lymphoid-primed hematopoietic stem cells (46). A similar 
observation in mice clarifies that L-selectin plays an essential role in trafficking 
and differentiation of stem cells. CD10 and CD62Lhi cells can differentiate into 
dendritic cells, monocytes, NK cells, B cells, and T cells. L-selectin expressed 
in these early progenitor cells is likely to be necessary for trafficking from the 
bone marrow to the peripheral lymphoid organs. It is not perfectly clear whether 
subsequent differentiation depends on L-selectin. (47,48) 
The leukocyte expresses on average 50,000–70,000 L-selectin molecules in 
the plasma membrane. Numerous reports have shown that L-selectin is 
targeted at finger-like projections called microvilli, which increases the 
effectiveness of anchoring during recruitment (49). Protein expression of L-
selectin is constitutive in most circulating leukocytes, and it slowly turns around 
in the plasma membrane through a process of detachment of the ectodomain 
(commonly called "shedding"). A variety of artificial or physiological agonists of 
cell activation can, within minutes, promote robust L-selectin release in 
numerous leukocyte subtypes). Zinc-dependent metalloproteinase, a 
disintegrin and metalloproteinase (ADAM) 17, is the main enzyme responsible 
for the release of L-selectin in leukocytes. However, ADAM 8 and 10 have also 
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been reported to cleave L-selectin in specific settings (59,60). From a clinical 
perspective, the soluble circulating form of L-selectin (released as a 
consequence of ectodomain clearance) is sometimes used as a plasma / 
serum surrogate biomarker for leukocyte activity triggered during acute or 
chronic inflammation (50-53). Similarly, leukocytes expressing low levels of 
surface L-selectin (examined by flow cytometric analysis) are a classic indicator 
of cellular activation (54). With the paradox that a drop in soluble L-selectin can 
also be detected in certain diseases, such as sepsis (55). The drop in 
detectable soluble L-selectin may be due to its adsorption to luminal vascular 
ligands that are regulated during sepsis. Alternatively, L-selectin could be 
cleaved from transmigrated neutrophils within the abluminal/non-luminal 
regions of the vessels. Although soluble L-selectin may compete for cell-
associated L-selectin, little is understood about how the two forms dampen 
leukocyte recruitment during inflammation. Soluble L-selectin is detected in the 
plasma of healthy humans (0.7-1.5 μg per ml), suggesting that cell-associated 
L-selectin is cleaved from circulating leukocytes at rest at low levels. Indeed, 
mouse neutrophils lacking ADAM17 express above-average surface levels of 
L-selectin (56). This phenomenon is also observed when synthetic broad-
spectrum inhibitors of ADAM17 are used, or when the L-selectin cleavage site 
is mutated and becomes "sheddase resistant" (57-60). The way that L-selectin 
expression is regulated, either at the translational or post-translational level, will 
be unique in different leukocyte subsets. For example, the lifespan of a central 
memory T cell (TCM) far exceeds the lifespan of a neutrophil (i.e. 6 weeks 
compared to 8 days, respectively) . Aging neutrophils have diminishing levels 
of L-selectin, which contrasts with MTC .The sections below provide some 
examples of how Lselectin is expressed in different leukocyte subsets and the 
impact this might have on the behavior of immune cells (60) 
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4. Role of L-selectin and involvement in inflammatory pathology. 
L-selectin is expressed in circulating neutrophils, monocytes, and eosinophils, 
and in most virgin B lymphocytes and T lymphocytes. L-selectin has been 
implicated in the adhesion process of neutrophils with activated endothelial 
cells, but not with quiescent endothelial cells, indicating that the ligand for L-
selectin is not constitutively present in endothelial cells. L-selectin-dependent 
leukocyte-endothelium interactions do not require leukocyte activation, as this 
molecule is constitutively expressed. In fact, the activation of leukocytes by 
inflammatory mediators or cytokines results in a decrease in the expression of 
L-selectin in the plasma membrane by shedding of this molecule. 
A characteristic that distinguishes L-selectin from the other members of his 
family is the way special regulation; various stimuli thatinclude 
chemoattractants, cytokines, and esters of phorbol induce the release of a 
fragment soluble of said molecule. Stimulating lymphocytes from BALB / c mice 
with phorbol esters, Preece et al. identified a metalloproteinase responsible 
zinc-dependent membrane of L-selectin proteolysis. He physiological 
significance of this phenomenon is not still know exactly, but it has been 
proposed that loss of L-selectin would allow leukocytes detach from the luminal 
surface of the vascular wall and initiate migration between endothelial cells; 
Furthermore, the soluble fragments of this molecule would bind to its ligands in 
endothelial cells adjacent to the site of inflammation and this shape would block 
the binding of other granulocytes to restrict their access to the area of 
injury.GlyCAM-1, found in the upper endothelial venules of the lymph nodes. 
L-Selectine Ligands 
CD34, found in endothelial cells. 
MadCAM-1, found in endothelial cells of lymphoid tissue associated with the 
intestine. 
PSGL-1 binds with low affinity.(70-75). 
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5. Hypothesis and objective 
L-selectin shedding was observed with granulocytes from all of the interleukin-1 
receptor-associated kinase-4-deficient patients on activation with agonists of 
Toll-like receptors 1/2, 2/6, 4, 7, and 8 and with granulocytes from all of the 
UNC-93B-deficient patients on activation with agonists of Toll-like receptors 7 
and 8. All of the healthy controls responded to these stimuli. 
L-Selectin shedding may be an indirect and easy method to study defects in 
immunodeficient patients in which defects in the phagocyte system are 
suspected. The laboratory work proposed was to set up the laboratory method 
to measure L-selectin shedding in peripheral blood mononuclear cells and 
implement such a practice to the Immunology Laboratory routine. 
6. Patients and Methods 
Heparin-treated blood was taken from 8 healthy control subjects after 
informed consent. We incubated 100 uL of blood for 1 hour without stimulation 
or with TLR4 agonist (LPS), or phorbolmyristyl acetate (PMA) at 2 mg/uL at 
37°C in a humidified atmosphere containing 5% CO2.. For all of the incubations 
the cells were first incubated with 10 g/mL of polymyxin B (Sigma, P-4932) for 
20 minutes. (74-76) 
The procedure is obtained starting with the heparin tubes to which the LPS 
and PMA stimuli are added, which are incubated 1 h at 37oC  
Once incubated, we added 500 ul of lysis buffer and then incubated 10 min at 
room temperature. 
Subsequently we introduced 500 ul of Isoflow buffer (Beckman Coulter) and 
incubated at room temperature for 5 min. 
Subsequently, we splited in two tubes and in one of them carried the CD62L. 
We then incubated 30 min and then obtained the cell pellet after centrifugation. 
The pellet was resuspended in 500 ul PBS to be acquired in the Flow 
Cytometer (Aquios,, Beckman Coulter). 
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7. Results 
• Expression without stimulus 
 
 
• Expression with stimulation of TLR4 
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• Expression with PMA + Ionomicin 
 
Figure is a representative histogram of one of the 8 healthy controls studied. 
Above histogram represents the signal of CD62L staining in unstimulated 
granulocytes (magenta) in comparison with the signal of unstimulated cells 
without antibody staining (autofluorescence in blue). 
The middle figure shows the CD62L staining in unstimulated granulocytes 
(magenta) and the CD62L shedding after stimulation with LPS (in red). 
The lower histogram represents the CD62L staining in unstimulated cells (blue) 
compared with the CD62L shedding in stimulated granulocytes with PMA + 
Ionomycin (red). 
 
 
Unfortunately, I must say that the Covid-19 pandemia has prevented me from far 
exceeding the test that is intended to be a future objective of study. The experiments 
with the 8 subjects were performed in the laboratory just before the outbreak of the 
pandemia.  This would be the basis to follow-up setting-up the laboratory protocol to 
introduce it the clinical routine testing of patients with phagocyte defects suspicion in 
the Primary Immunodeficiency Clinics. 
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8.CONCLUSIONS 
 
Understanding the role of l-selectin is key to understanding its role in the 
acute inflammation reaction and subsequently applying the relevant 
technique that can adhere to the possibility of immunodeficiencies. 
The situation of the coronavirus will not prevent the project from continuing 
and it can be developed in the near future. 
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